Printer's No. PN3850
See other bills
under the
same topic PRINTER'S NO. 3850 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.605 Session of 2026 INTRODUCED BY BRENNAN, RIVERA, VENKAT AND DOUGHERTY, AUGUST 31, 2026 REFERRED TO COMMITTEE ON HEALTH, AUGUST 31, 2026 A RESOLUTIONRecognizing the month of September 2026 as "Chiari Malformation Awareness Month" in Pennsylvania.WHEREAS, Chiari malformations can occur when part of the skull does not form properly, causing nerve tissues to become crowded, pushing part of the cerebellum down and obstructing the flow of cerebrospinal fluid into the spinal canal; andWHEREAS, There are currently four recognized, distinct types of Chiari malformations, each with varying symptoms; andWHEREAS, Doctors and scientists are also investigating two additional types of Chiari malformations; andWHEREAS, Differentiation between each type occurs based on the presence of developmental abnormalities and the type of brain tissue that is compressed into the spinal canal; andWHEREAS, Chiari malformations are typically congenital, but may develop after birth or as the result of a mass in the brain or due to a traumatic injury or infection; andWHEREAS, These malformations may be diagnosed using magnetic resonance imaging or computed tomography technology; and123456789101112131415161718 WHEREAS, Conditions that are often associated with Chiari malformation include spina bifida, hydrocephalus, idiopathic intracranial hypertension and tethered cord syndrome; andWHEREAS, Syringomyelia and Ehlers-Danlos Syndrome may also co-occur with Chiari malformations; andWHEREAS, With syringomyelia, a syrinx, or cavity, forms in the spinal cord and can expand over time, eventually damaging the middle of the spinal cord in severe cases; andWHEREAS, Syringomyelia can develop without a Chiari malformation, but many syringomyelia cases are related to congenital Chiari malformations; andWHEREAS, Ehlers-Danlos Syndrome affects the body's connective tissue and can include symptoms such as hypermobility and tissue fragility; andWHEREAS, On average, symptoms related to co-occurring Chiari malformations and Ehlers-Danlos Syndrome begin earlier than symptoms affecting the wider population of individuals who have a Chiari malformation; andWHEREAS, Management of both a Chiari malformation and Ehlers-Danlos Syndrome can be complex due to instability of the head and neck region, further impacted by the increased risk of cerebrospinal fluid leaks for these individuals; andWHEREAS, Among individuals who have a Chiari malformation, co-occurring Ehlers-Danlos Syndrome may negatively impact their surgical outcomes, cause unusual symptoms and necessitate adjusted treatment plans; andWHEREAS, Early diagnosis of Chiari malformations and access to treatment can help with symptom management and improve the individual's quality of life; andWHEREAS, While there is no cure for Chiari malformations, 20260HR0605PN3850 - 2 - 123456789101112131415161718192021222324252627282930 depending on the type and severity of the Chiari malformation, surgeries, including posterior fossa decompression or spinal laminectomy, may relieve symptoms; andWHEREAS, Estimates show that approximately 80% of adults who have a Chiari malformation and pursued surgery reported an improvement in their symptoms; andWHEREAS, Chiari malformations are estimated to impact about 1 out of every 1,000 individuals; andWHEREAS, "Chiari Malformation Awareness Month" is recognized every September to increase awareness of the condition and to educate patients and their communities; andWHEREAS, In recognizing "Chiari Malformation Awareness Month," the House of Representatives brings awareness to Chiari malformations and available treatment options; therefore be itRESOLVED, That the House of Representatives recognize the month of September 2026 as "Chiari Malformation Awareness Month" in Pennsylvania.20260HR0605PN3850 - 3 - 1234567891011121314151617
under the
same topic PRINTER'S NO. 3850 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.605 Session of 2026 INTRODUCED BY BRENNAN, RIVERA, VENKAT AND DOUGHERTY, AUGUST 31, 2026 REFERRED TO COMMITTEE ON HEALTH, AUGUST 31, 2026 A RESOLUTIONRecognizing the month of September 2026 as "Chiari Malformation Awareness Month" in Pennsylvania.WHEREAS, Chiari malformations can occur when part of the skull does not form properly, causing nerve tissues to become crowded, pushing part of the cerebellum down and obstructing the flow of cerebrospinal fluid into the spinal canal; andWHEREAS, There are currently four recognized, distinct types of Chiari malformations, each with varying symptoms; andWHEREAS, Doctors and scientists are also investigating two additional types of Chiari malformations; andWHEREAS, Differentiation between each type occurs based on the presence of developmental abnormalities and the type of brain tissue that is compressed into the spinal canal; andWHEREAS, Chiari malformations are typically congenital, but may develop after birth or as the result of a mass in the brain or due to a traumatic injury or infection; andWHEREAS, These malformations may be diagnosed using magnetic resonance imaging or computed tomography technology; and123456789101112131415161718 WHEREAS, Conditions that are often associated with Chiari malformation include spina bifida, hydrocephalus, idiopathic intracranial hypertension and tethered cord syndrome; andWHEREAS, Syringomyelia and Ehlers-Danlos Syndrome may also co-occur with Chiari malformations; andWHEREAS, With syringomyelia, a syrinx, or cavity, forms in the spinal cord and can expand over time, eventually damaging the middle of the spinal cord in severe cases; andWHEREAS, Syringomyelia can develop without a Chiari malformation, but many syringomyelia cases are related to congenital Chiari malformations; andWHEREAS, Ehlers-Danlos Syndrome affects the body's connective tissue and can include symptoms such as hypermobility and tissue fragility; andWHEREAS, On average, symptoms related to co-occurring Chiari malformations and Ehlers-Danlos Syndrome begin earlier than symptoms affecting the wider population of individuals who have a Chiari malformation; andWHEREAS, Management of both a Chiari malformation and Ehlers-Danlos Syndrome can be complex due to instability of the head and neck region, further impacted by the increased risk of cerebrospinal fluid leaks for these individuals; andWHEREAS, Among individuals who have a Chiari malformation, co-occurring Ehlers-Danlos Syndrome may negatively impact their surgical outcomes, cause unusual symptoms and necessitate adjusted treatment plans; andWHEREAS, Early diagnosis of Chiari malformations and access to treatment can help with symptom management and improve the individual's quality of life; andWHEREAS, While there is no cure for Chiari malformations, 20260HR0605PN3850 - 2 - 123456789101112131415161718192021222324252627282930 depending on the type and severity of the Chiari malformation, surgeries, including posterior fossa decompression or spinal laminectomy, may relieve symptoms; andWHEREAS, Estimates show that approximately 80% of adults who have a Chiari malformation and pursued surgery reported an improvement in their symptoms; andWHEREAS, Chiari malformations are estimated to impact about 1 out of every 1,000 individuals; andWHEREAS, "Chiari Malformation Awareness Month" is recognized every September to increase awareness of the condition and to educate patients and their communities; andWHEREAS, In recognizing "Chiari Malformation Awareness Month," the House of Representatives brings awareness to Chiari malformations and available treatment options; therefore be itRESOLVED, That the House of Representatives recognize the month of September 2026 as "Chiari Malformation Awareness Month" in Pennsylvania.20260HR0605PN3850 - 3 - 1234567891011121314151617
Texto oficial de la Legislatura de Pennsylvania. El formato se adaptó para leerlo en Ratifi.